
European Pharmaceutical Manufacturer editor, Olivia Friett, discusses the integration of AI in pharmaceutical manufacturing.
It feels like we’ve been talking about AI in pharma for years now. Every panel discussion, every strategy report, every exhibition floor seems to promise transformation. And while the ambition has certainly been there, I’ve often found myself wondering, beyond the pilot projects, is AI genuinely making a difference where it matters most?
In the early days, much of the excitement centred on drug discovery. Companies in the past…